Lichen sclerosus and immune checkpoint inhibitors: A case and review of the literature

Australas J Dermatol. 2023 Feb;64(1):158-161. doi: 10.1111/ajd.13941. Epub 2022 Oct 31.

Kelvin Truong^{1

2}, Maria Jones-Caballero^{1

2}, Shaun Chou^{1

3}, Matteo S Carlino^{1

4

5}, Germana Consuegra-Romero^{1

2}, Raquel Ruiz Araujo^{1

2}

¹ Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Camperdown, New South Wales, Australia.
² Department of Dermatology, Westmead Hospital, Westmead, New South Wales, Australia.
³ Department of Tissue Pathology and Diagnostic Oncology, Institute of Clinical Pathology and Medical Research (ICPMR), Westmead Hospital, NSW Health Pathology, Westmead, New South Wales, Australia.
⁴ Department of Medical Oncology, Westmead Hospital, Westmead, New South Wales, Australia.
⁵ Melanoma Institute Australia, Wollstonecraft, New South Wales, Australia.

No abstract available

Publication types